NCT05168358

Brief Summary

We hypothesize that overnight catheter drainage (OCD) of the urinary bladder might improve bladder dynamics and subsequently lead to improvement or resolution of hydronephrosis (HN) and renal function in boys who underwent PUV ablation. Patients who have persistent HN and bladder dysfunction at least one year after PUV ablation will be randomly allocated into two groups: the first group (control group): 55 patients, their parents will be taught the timed voiding regimen every 2 hours, while the second group (OCD group): 55 patients, their parents will be taught the timed voiding regimen every 2 hours, in addition to placing an overnight catheter to drain the urinary bladder during night. We will study the effect of OCD of the urinary bladder on the improvement or resolution of HN and urinary bladder function within a year of starting this regimen.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
55

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Dec 2021

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 12, 2021

Completed
Same day until next milestone

Study Start

First participant enrolled

December 12, 2021

Completed
11 days until next milestone

First Posted

Study publicly available on registry

December 23, 2021

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 12, 2022

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 12, 2023

Completed
Last Updated

December 23, 2021

Status Verified

December 1, 2021

Enrollment Period

1 year

First QC Date

December 12, 2021

Last Update Submit

December 12, 2021

Conditions

Keywords

Overnight Catheter DrainagePosterior Urethral ValveRandomized Controlled Trial

Outcome Measures

Primary Outcomes (1)

  • Improvement or Resolution of Hydronephrosis

    Impact of overnight bladder drainage on improvement or resolution of hydronephrosis assessed by renal and bladder ultrasonography. Improvement of hydronephrosis will be defined as downgrading of hydronephrosis according to Society of Fetal Urology grading system.

    One Year

Secondary Outcomes (1)

  • Improvement of Bladder and Renal Function and Resolution of Urinary Tract Infection

    One Year

Study Arms (2)

Control group

NO INTERVENTION

This arm will include 55 patients, their parents will be taught the timed voiding regimen every 2 hours.

OCD group

EXPERIMENTAL

This arm will include 55 patients, their parents will be taught the timed voiding regimen every 2 hours, in addition to placing an overnight catheter to drain the urinary bladder during night.

Procedure: Overnight Bladder Drainage

Interventions

Parents or caregivers of the patients will be taught to place an indwelling catheter in the bladder at bedtime for about 8-12 h under a clean technique every night for one year. The catheter will then be allowed to drain freely into a gravity drainage collecting bag or in the diapers. On the next morning, the catheter will be removed and the timed voiding regimen will be resumed.

Also known as: Overnight Catheter Drainage
OCD group

Eligibility Criteria

Age1 Year - 18 Years
Sexmale(Gender-based eligibility)
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Persistent hydronephrosis and
  • Unfavorable bladder dynamics on urodynamic study performed at least one year after posterior urethral valve ablation will be included in the study. The unfavorable bladder dynamics will be defined as poor compliance or detrusor overactivity.

You may not qualify if:

  • Underwent urinary diversion (e.g. vesicostomy or ureterostomy),
  • Have other conditions that could affect lower urinary tract function,
  • Have infravesical obstruction or
  • Those who will refuse to participate in the study will be excluded.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Urology and Nephrology Center

Al Mansurah, DK, Egypt

RECRUITING

Study Officials

  • Ahmed Elkashef

    Urology and Nephrology Center, Mansoura University, Egypt

    PRINCIPAL INVESTIGATOR
  • Ahmed Abdelhalim

    Urology and Nephrology Center, Mansoura University, Egypt

    STUDY DIRECTOR
  • Ashraf Hafez

    Urology and Nephrology Center, Mansoura University, Egypt

    STUDY DIRECTOR
  • Mohamed Dawaba

    Urology and Nephrology Center, Mansoura University, Egypt

    STUDY DIRECTOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Ahmed Elkashef

Study Record Dates

First Submitted

December 12, 2021

First Posted

December 23, 2021

Study Start

December 12, 2021

Primary Completion

December 12, 2022

Study Completion

June 12, 2023

Last Updated

December 23, 2021

Record last verified: 2021-12

Data Sharing

IPD Sharing
Will not share

Locations